Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005

Antimicrob Agents Chemother. 2007 Aug;51(8):3001-3. doi: 10.1128/AAC.00256-07. Epub 2007 May 25.

Abstract

Clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 through 2005 at a tertiary care center were studied for qnr genes. Isolates bearing these genes emerged in the mid-1990s, coinciding with the time of a rapid increase in fluoroquinolone resistance. Sixty percent of these isolates were ciprofloxacin susceptible by CLSI breakpoints.

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Bacteremia / epidemiology*
  • Bacteremia / microbiology
  • Bacterial Proteins / genetics*
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Bacterial* / genetics
  • Enterobacter* / classification
  • Enterobacter* / drug effects
  • Enterobacter* / genetics
  • Enterobacter* / isolation & purification
  • Enterobacteriaceae Infections / epidemiology
  • Enterobacteriaceae Infections / microbiology
  • Humans
  • Israel / epidemiology
  • Klebsiella Infections / epidemiology
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae* / drug effects
  • Klebsiella pneumoniae* / genetics
  • Klebsiella pneumoniae* / isolation & purification
  • Microbial Sensitivity Tests / standards
  • Prevalence

Substances

  • Anti-Infective Agents
  • Bacterial Proteins
  • Qnr protein, Klebsiella pneumoniae
  • Ciprofloxacin